Doctor Jonas Goldin Diness
Acesion Pharma, Copenhagen (Denmark)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
The SK channel inhibitor AP30663, converts vernakalant-resistant persistent AF and prevents its reinduction in pigs
Event: ESC Congress 2019
Topic: Antiarrhythmic Pharmacotherapy
Session: Preclinical pharmacotherapy
Novel negative, allosteric modulator inhibits small conductance Ca2+-activated K+-channels and selectively prolongs atrial refractoriness in conscious pigs
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Atrial fibrillation mechanisms
Inhibition of small conductance Ca2+-activated K+-Channels converts and prevents reinduction of atrial fibrillation in pigs where vernakalant fails
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Mechanism of arrhythmia in atrial fibrillation . New data on remodelling biomarkers and anti-arrhythmic drugs
ESC 365 is supported by
